K7N5M4 (K7N5M4_HUMAN) Homo sapiens (Human)
Human nkt tcr beta chain UniProtKBInterProInteractive Modelling
259 aa; Sequence (Fasta)
No models have been built for this target sequence.
Available Structures
24 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| MHC-like protein complex structure |
Heteromer K7N5N2; P01887; P11609; | 2×NAG; 1×NAG; 1×QOD; 1×HP6; | ||||
| Assess | ||||||
| NYBR1-A2-SLSKILDTV |
Heteromer A0A0B4J277; A0A584; K7N5M3; P04439; P61769; Q9BXX3; | 1×PEG; 2×EDO; 3×GOL; 8×SO4; 1×EPE; | ||||
| Assess | ||||||
| Human Leukocyte Antigen A02 presenting ILAKFLHWL, in complex with cognate T-Cell Receptor |
Heteromer A0A0B4J277; A0A0K0K1A5; K7N5M3; O14746; P04439; P61769; | 5×EDO; 1×GOL; 5×SO4; | ||||
| Assess | ||||||
| TCR589 in complex with HIV(Pol448-456)/HLA-B35 |
Heteromer P01889; P04585; P61769; Q6IRV4; | 1×NAG; 3×ZN; 1×NAG; | ||||
| Assess | ||||||
| The complex between high-affinity TCR DMF5(alpha-D26Y,beta-L98W) and human Class I MHC HLA-A2 with … |
Heteromer K7N5M3; P04439; P61769; Q16655; | |||||
| Assess | ||||||
| Structure of alpha-GC[8,18] bound by CD1d and in complex with the Va14Vb8.2 TCR |
Heteromer K7N5M3; P01887; P11609; | 1×NAG; 2×NAG; 1×PBS; 1×PLM; | ||||
| Assess | ||||||
| Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and V… |
Heteromer A0A0B4J240; K7N5M3; P15813; P61769; | 1×NAG; 1×AGH; | ||||
| Assess | ||||||
| TCR55 in complex with Pep20/HLA-B35 |
Heteromer P01889; P61769; Q6IRV4; | 27×GOL; 4×PO4; | ||||
| Assess | ||||||
| TCR55 in complex with HIV(Pol448-456)/HLA-B35 |
Heteromer P01889; P04585; P61769; Q6IRV4; | 3×EDO; 5×SO4; | ||||
| Assess | ||||||
| HLA-TCR complex |
Heteromer A0A0U5IHY9; K7N5N2; P16315; Q08AS3; | 3×NAG; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of a human Valpha24(-) NKT TCR in complex with CD1d/alpha-galactosylceramide |
Heteromer K7N5M3; P15813; P61769; | 5×NAG; 1×AGH; 1×FUC; 2×GOL; | ||||
| Assess | ||||||
| Structure of the DP10.7 TCR |
Heteromer Q6PJ56; | |||||
| Assess | ||||||
| Gag:02 TCR in complex with HLA-E. |
Heteromer A0A075B6U7; A0A0B4J268; A0A0J9YX06; B6S6I4; P04435; P0DSE1; P13747; P61769; | |||||
| Assess | ||||||
| Gag:02 TCR in complex with HLA-E featuring a non-natural amino acid |
Heteromer A0A075B6U7; A0A0B4J268; A0A0J9YX06; P04435; P0DSE1; P13747; P61769; | |||||
| Assess | ||||||
| 6218 TCR in complex with H2-Db PA 224 |
Heteromer A0A075B6C4; A0A0G2LB96; K7N5N2; O89752; P01899; P61769; | 4×NA; | ||||
| Assess | ||||||
| 6218 TCR in complex with H2Db PA with an engineered TCR-pMHC disulfide bond |
Heteromer A0A075B6C4; A0A0G2LB96; K7N5N2; O89752; P01899; P61769; | 1×NA; | ||||
| Assess | ||||||
| 6218 TCR in complex with H2-Db PA224-233 with a cysteine mutant |
Heteromer A0A075B6C4; A0A0G2LB96; K7N5N2; O89752; P01899; P61769; | 4×NA; | ||||
| Assess | ||||||
| Crystal Structure of 6218 TCR in complex with the H2Db-PA224 |
Heteromer A0A075B6C4; A0A0G2LB96; K7N5N2; P01887; P01899; P13175; | |||||
| Assess | ||||||
| Crystal Structure of H-2Db with the GAP501 peptide (SQL) |
Heteromer A0A075B616; A0A0Y9W4B5; K7N5M3; P01887; P01899; P04213; | 1×NA; 1×CL; | ||||
| Assess | ||||||
| The complex among DMF5(alpha-D26Y, alpha-Y50A,beta-L98W) TCR, human Class I MHC HLA-A2 and MART-1(2… |
Heteromer A0A075B6T6; A0A1B0GXE1; P01848; P04439; P61769; Q16655; | |||||
| Assess | ||||||
| Crystal structure of the KFJ5 TCR |
Heteromer A0A0B4J268; A0A5B6; K7N5N2; | |||||
| Assess | ||||||
| Computational Stabilization of T Cell Receptor Constant Domains |
Heteromer Q2YD82; | 3×MG; | ||||
| Assess | ||||||
| Structure of the AB18.1 TCR |
Heteromer A2NUW5; K7N5M3; Q6PJ56; | |||||
| Assess | ||||||
| Engineered Human HLA_A2 MHC Class I molecule in complex with TCR and SV9 peptide |
Heteromer A0A0B4J279; A0A0K0K1A5; K7N5N2; P04439; P61769; | 1×GOL; 1×ACT; | ||||
| Assess | ||||||